This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Block & Leviton LLP Investigates Catalyst Health Solutions, Inc.'s Board Of Directors For Possible Breaches Of Their Fiduciary Duties

BOSTON, April 18, 2012 /PRNewswire/ -- Block & Leviton LLP (, a Boston-based law firm representing investors nationwide, is investigating possible breaches of fiduciary duties by the Board of Directors of Catalyst Health Solutions, Inc. ("Catalyst" or the "Company") (Nasdaq: CHSI) with regard to a proposed sale of the Company. 

Before trading opened on April 18, 2012, Catalyst announced that it had entered into an Agreement and Plan of Merger with SXC Health Solutions Corp. ("SXC") (Nasdaq: SXCI), pursuant to which SXC will acquire Catalyst for a per share price of $28 in cash plus .6606 of a share of SXC.  In a press release issued this morning, SXC touted the purchase price as totaling $81.02 per share, which would represent a premium of 28% over Catalyst's closing price yesterday.  However, SXC has seen its stock price climb steeply over the last six months from a low of approximately $40 per share as recently as October 2011.  Using SXC's average price over the previous year ($58.86) instead of SXC's closing price yesterday ($80.27), the offer price would be $66.88 per share, which would represent a premium of only 5% over Catalyst's closing price yesterday.   

Block & Leviton's investigation seeks to determine, among other things, whether Catalyst's Board of Directors has breached their fiduciary duties by failing to maximize shareholder value in the proposed transaction.  If you have any information relevant to this investigation, or if you have questions about your legal rights, please contact Block & Leviton LLP.

Block & Leviton is a Boston-based law firm representing investors for violations of the securities laws.  The firm's lawyers have collectively been prosecuting securities cases on behalf of investors for over 50 years.

This notice may constitute attorney advertising.  

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
FB $117.50 0.66%
GOOG $694.71 0.53%
TSLA $241.45 -2.50%
YHOO $36.64 0.14%
AAPL $93.85 -1.00%


Chart of I:DJI
DOW 17,805.62 -25.14 -0.14%
S&P 500 2,060.07 -15.74 -0.76%
NASDAQ 4,764.12 -41.1710 -0.86%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs